BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3951313)

  • 1. The effect of intracerebroventricular 5,7-dihydroxytryptamine on morphine analgesia is time-dependent.
    Romandini S; Pich EM; Esposito E; Kruszewska AZ; Samanin R
    Life Sci; 1986 Mar; 38(10):869-75. PubMed ID: 3951313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of clonidine-induced analgesia by lesions induced with spinal and intracerebroventricular administration of 5,7-dihydroxytryptamine.
    Duan J; Sawynok J
    Neuropharmacology; 1987 Apr; 26(4):323-9. PubMed ID: 3587536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tail temperature in rats after intraventricular injections of 6-hydroxydopamine or 5,7-dihydroxytryptamine.
    Ishikawa Y; Matuszek M; Nakayama T
    Neurosci Lett; 1980 Nov; 20(2):177-81. PubMed ID: 7443067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of spinal cord serotonin depletion to alter analgesia elicited from the periaqueductal gray.
    Johannessen JN; Watkins LR; Carlton SM; Mayer DJ
    Brain Res; 1982 Apr; 237(2):373-86. PubMed ID: 7083001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrathecal administration of 5,6-DHT or 5,7-DHT reduces morphine and substance P-antinociceptive activity in the rat.
    Rodríguez FD; Rodríguez RE
    Neuropeptides; 1989; 13(2):139-46. PubMed ID: 2472573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of central 5-HT receptors and their adaptive changes following intracerebral 5,7-dihydroxytryptamine administration in the rat.
    Nelson DL; Herbet A; Bourgoin S; Glowinski J; Hamon M
    Mol Pharmacol; 1978 Nov; 14(6):983-95. PubMed ID: 732817
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of neonatal spinal cord serotonin depletion on opiate-induced analgesia in tests of thermal and mechanical pain.
    Giordano J; Barr GA
    Brain Res; 1988 Jun; 469(1-2):121-7. PubMed ID: 3401795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supersensitivity of 5,7-dihydroxytryptamine-treated rats to the respiratory depressant and antitussive effects of dihydrocodeine.
    Kamei J; Ogawa M; Kasuya Y
    Eur J Pharmacol; 1988 Aug; 153(2-3):305-8. PubMed ID: 3181291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal intraspinal 6-hydroxydopamine, 5,7-dihydroxytryptamine or their combination: effects on nociception and morphine analgesia.
    Pappas B; Ings R; Roberts D
    Eur J Pharmacol; 1982 Dec; 86(2):157-66. PubMed ID: 6819155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of different lesions of the median raphe on morphine analgesia.
    Romandini S; Pich EM; Esposito E; Kruszewska A; Samanin R
    Brain Res; 1986 Jul; 377(2):351-4. PubMed ID: 3730868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin reuptake inhibitors do not prevent 5,7-dihydroxytryptamine-induced depletion of serotonin in rat brain.
    Choi S; Jonak E; Fernstrom JD
    Brain Res; 2004 May; 1007(1-2):19-28. PubMed ID: 15064132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of footshock-induced analgesia by spinal 5,7-dihydroxytryptamine lesions.
    Hutson PH; Tricklebank MD; Curzon G
    Brain Res; 1982 Apr; 237(2):367-72. PubMed ID: 7083000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5,7-Dihydroxytryptamine modifies excitability of rat dorsal raphe serotonergic neurons in vitro.
    Segal M
    Neurosci Lett; 1986 Nov; 71(3):306-10. PubMed ID: 3796886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of selective destruction of serotonergic neurons in nucleus raphe magnus on morphine-induced antinociception.
    Mohrland JS; Gebhart GF
    Life Sci; 1980 Dec 22-29; 27(25-26):2627-32. PubMed ID: 7219034
    [No Abstract]   [Full Text] [Related]  

  • 15. Immediate and long-term effects of 5,7-dihydroxytryptamine on rat striatal serotonergic neurons measured using in vivo voltammetry.
    Nakazato T; Akiyama A
    Neurochem Res; 1998 Jan; 23(1):1-6. PubMed ID: 9482260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in seizure susceptibility after intracerebral treatment with 5,7-dihydroxytryptamine: role of serotonergic neurons.
    Browning RA; Hoffmann WE; Simonton RL
    Ann N Y Acad Sci; 1978 Jun; 305():437-56. PubMed ID: 280255
    [No Abstract]   [Full Text] [Related]  

  • 17. Retzius cells retain functional membrane properties following 'ablation' by the neurotoxin 5,7-DHT.
    Lent CM; Dickinson MH
    Brain Res; 1984 May; 300(1):167-71. PubMed ID: 6329427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5,7-dihydroxytryptamine-induced mouse killing and behavioral reversal with ventricular administration of serotonin in rats.
    Applegate CD
    Behav Neural Biol; 1980 Oct; 30(2):178-90. PubMed ID: 7192550
    [No Abstract]   [Full Text] [Related]  

  • 19. Function of serotonin in physiologic secretion of growth hormone and prolactin: action of 5,7-dihydroxytryptamine, fenfluramine and p-chlorophenylalanine.
    Willoughby JO; Menadue M; Jervois P
    Brain Res; 1982 Oct; 249(2):291-9. PubMed ID: 6291713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased tryptophan hydroxylase activity in serotonergic nerve terminals spared by 5,7-dihydroxytryptamine.
    Stachowiak MK; Stricker EM; Jacoby JH; Zigmond MJ
    Biochem Pharmacol; 1986 Apr; 35(8):1241-8. PubMed ID: 2421731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.